Lv5
1350 积分 2025-09-19 加入
Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeutics
1个月前
已完结
Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations
1个月前
已完结
Preclinical Pharmacokinetic Study on Caffeine as an Excipient for Monoclonal Antibody Formulations
1个月前
已关闭
Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions
1个月前
已完结
HP-β-CD for the formulation of IgG and Ig-based biotherapeutics
1个月前
已完结
Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry
1个月前
已完结
Investigation on the Combined Effect of Hydroxypropyl Beta-Cyclodextrin (HPβCD) and Polysorbate in Monoclonal Antibody Formulation
1个月前
已完结
Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies
1个月前
已完结
Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development
2个月前
已完结
A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design
6个月前
已完结
皖公网安备34019202002308
